基本信息
views: 105
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Alessio Cortellini is a consultant medical oncologist and clinical scientist with a special interest on immunotherapy of cancer.
He graduated with honors at the University of L’Aquila in Italy, where he also completed his residency training in medical oncology. After leading the immunotherapy program at University of L’Aquila for more than a year he has moved to London in 2020.
Alessio currently works as visiting researcher at Imperial College London and as medical oncologist at Imperial College Healthcare NHS Trust, Hammersmith hospital, in the early phase clinical trial unit.
Alessio’s research efforts on clinical research in immuno-oncology have been recognized with the Berlucchi Foundation award for the "Best Poster" presented at the XXI AIOM (Italian Association of Medical Oncology) National Congress and the Federico Calabresi award for the "Best publication of the year on a high impact factor international journal" at the 21st Edition of the "Grandangolo in Oncology" in 2019.
He was also named recipient of the third “Annual Young Investigator Award 2020”, by the editors of The Oncologist journal for a manuscript exploring the use of immune-checkpoint inhibitors in patients with pre-existing autoimmune diseases.
Alessio is an AIOM member and a member of the AIOM National Scientific Committee (Mandate: 2020-2021); he also is an ESMO (European Society of Medical Oncology) and SITC (Society for Immunotherapy of Cancer) member and served as external evaluator for the French National Cancer Institute (INCa).
He presented poster/oral communications in several national and international meetings (including ASCO, ESMO and AACR meetings) and has authored/co-authored a number of full text publications. Alessio also served as reviewer for many peer-reviewed international journals in the field of oncology.
He graduated with honors at the University of L’Aquila in Italy, where he also completed his residency training in medical oncology. After leading the immunotherapy program at University of L’Aquila for more than a year he has moved to London in 2020.
Alessio currently works as visiting researcher at Imperial College London and as medical oncologist at Imperial College Healthcare NHS Trust, Hammersmith hospital, in the early phase clinical trial unit.
Alessio’s research efforts on clinical research in immuno-oncology have been recognized with the Berlucchi Foundation award for the "Best Poster" presented at the XXI AIOM (Italian Association of Medical Oncology) National Congress and the Federico Calabresi award for the "Best publication of the year on a high impact factor international journal" at the 21st Edition of the "Grandangolo in Oncology" in 2019.
He was also named recipient of the third “Annual Young Investigator Award 2020”, by the editors of The Oncologist journal for a manuscript exploring the use of immune-checkpoint inhibitors in patients with pre-existing autoimmune diseases.
Alessio is an AIOM member and a member of the AIOM National Scientific Committee (Mandate: 2020-2021); he also is an ESMO (European Society of Medical Oncology) and SITC (Society for Immunotherapy of Cancer) member and served as external evaluator for the French National Cancer Institute (INCa).
He presented poster/oral communications in several national and international meetings (including ASCO, ESMO and AACR meetings) and has authored/co-authored a number of full text publications. Alessio also served as reviewer for many peer-reviewed international journals in the field of oncology.
Research Interests
Papers共 325 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Amin H. Nassar,Talal El Zarif,Ahmed Bilal Khalid, Serena Rahme, Caiwei Zhong,Lucia Kwak,Marita Salame,Elias Bou Farhat,Dory Freeman,Edward El-Am, Arjun Ravishankar, Bachar Ahmad,
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 3 (2024)
crossref(2024)
Clinical lung cancerno. 2 (2024): 190-195
crossref(2024)
Journal of Endocrinological Investigationpp.1-14, (2024)
crossref(2024)
crossref(2024)
crossref(2024)
crossref(2024)
EUROPEAN JOURNAL OF CANCER (2024): 114006-114006
Load More
Author Statistics
#Papers: 329
#Citation: 4135
H-Index: 33
G-Index: 58
Sociability: 8
Diversity: 3
Activity: 209
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn